# Anti-diabetic Drugs and Fatty Liver Management

> **NCT05041673** · NA · UNKNOWN · sponsor: **Alexandria University** · enrollment: 120 (estimated)

## Conditions studied

- Fatty Liver, Nonalcoholic
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT05041673
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-23
- **Primary completion:** 2021-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05041673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05041673, "Anti-diabetic Drugs and Fatty Liver Management". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05041673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*